The United States and Saudi Arabia are “days away” from concluding the documents that would forge a historic bilateral agreement that has long been a top priority...
The biotech still hasn’t lost momentum. Vaccine maker Novavax (NVAX -9.65%) isn’t dead in the water after all. Though the past 18 months have been tough...
Vaccine maker Novavax (NASDAQ: NVAX) isn’t dead in the water after all. Though the past 18 months have been tough — and management warned investors that...